Format

Send to

Choose Destination
See comment in PubMed Commons below
Clin Exp Dermatol. 2002 Sep;27(6):516-8.

Topical 5-ALA photodynamic therapy for the treatment of cutaneous T-cell lymphoma.

Author information

1
University Department of Dermatology, Western Infirmary, Glasgow, UK.

Abstract

Therapeutic options for cutaneous T cell lymphoma (CTCL) include topical steroids, topical chemotherapy and phototherapy. Patients with limited disease that is unresponsive to these therapies present a particular challenge. We report successful treatment of a patient with two plaques of CTCL using topical photodynamic therapy (PDT). 5-aminolaevulinic acid (5-ALA) was applied 6-24 h preillumination with 100 J/cm2 red light. Treatment was repeated on four occasions with clinical and histological clearance. ALA-PDT may be a useful addition to the therapeutic options for CTCL. Further studies are required to define optimal treatment protocols.

PMID:
12372098
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley
    Loading ...
    Support Center